Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
Clinical trial NCT03301896 · TERMINATED
Trial details
- NCT number
- NCT03301896
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2022-06-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.